JP2013535477A5 - - Google Patents

Download PDF

Info

Publication number
JP2013535477A5
JP2013535477A5 JP2013522132A JP2013522132A JP2013535477A5 JP 2013535477 A5 JP2013535477 A5 JP 2013535477A5 JP 2013522132 A JP2013522132 A JP 2013522132A JP 2013522132 A JP2013522132 A JP 2013522132A JP 2013535477 A5 JP2013535477 A5 JP 2013535477A5
Authority
JP
Japan
Prior art keywords
polyethylene glycol
noge
emissions
mpa
ion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013522132A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013535477A (ja
JP5937593B2 (ja
Filing date
Publication date
Priority claimed from EP10008104A external-priority patent/EP2415460A1/de
Application filed filed Critical
Publication of JP2013535477A publication Critical patent/JP2013535477A/ja
Publication of JP2013535477A5 publication Critical patent/JP2013535477A5/ja
Application granted granted Critical
Publication of JP5937593B2 publication Critical patent/JP5937593B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013522132A 2010-08-03 2011-08-02 プレガバリンの経口投与剤形 Active JP5937593B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10008104.1 2010-08-03
EP10008104A EP2415460A1 (de) 2010-08-03 2010-08-03 Orale Darreichungsform von Pregabalin
PCT/EP2011/003873 WO2012016683A2 (en) 2010-08-03 2011-08-02 Oral dosage form of pregabalin

Publications (3)

Publication Number Publication Date
JP2013535477A JP2013535477A (ja) 2013-09-12
JP2013535477A5 true JP2013535477A5 (https=) 2016-02-18
JP5937593B2 JP5937593B2 (ja) 2016-06-22

Family

ID=43216378

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013522132A Active JP5937593B2 (ja) 2010-08-03 2011-08-02 プレガバリンの経口投与剤形

Country Status (6)

Country Link
US (1) US20130149253A1 (https=)
EP (2) EP2415460A1 (https=)
JP (1) JP5937593B2 (https=)
KR (1) KR20140003376A (https=)
CA (1) CA2806752A1 (https=)
WO (1) WO2012016683A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2849733B1 (en) * 2011-12-19 2020-04-08 Mahmut Bilgic Effervescent pharmaceutical formulations comprising pregabalin and vitamin b12
WO2013100873A1 (en) * 2011-12-19 2013-07-04 Mahmut Bilgic Pharmaceutical formulation of pregabalin (particle size 300-2500 micrometer)
WO2013100874A1 (en) * 2011-12-19 2013-07-04 Mahmut Bilgic Effervescent pregablin formulation
MX2013001278A (es) * 2013-01-31 2014-07-30 Miguel Ángel García Pérez Composicion farmaceutica con un sistema bifasico de liberacion inmediata para el control de eventos convulsivos y del dolor.
US9913803B2 (en) * 2013-08-26 2018-03-13 Amorsa Therapeutics, Inc. Single-layer oral dose of neuro-attenuating ketamine
IN2014MU00198A (https=) * 2014-01-21 2015-08-28 Intas Pharmaceuticals Ltd
PL235144B1 (pl) * 2014-06-03 2020-06-01 Univ Medyczny Im Piastow Slaskich We Wroclawiu Sposób wytwarzania tabletki flotacyjnej o przedłużonym oddziaływaniu substancji leczniczych z błoną śluzową żołądka oraz kompozycja farmaceutyczna
CN104561442B (zh) * 2014-10-23 2017-05-31 东莞市佳平装饰材料有限公司 一种核电用347奥氏体不锈钢的制备方法
WO2016062182A1 (zh) * 2014-10-24 2016-04-28 江苏恒瑞医药股份有限公司 一种普瑞巴林缓释制剂
JP6919119B2 (ja) * 2017-01-23 2021-08-18 日新製薬株式会社 ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。
KR102039344B1 (ko) * 2017-02-01 2019-11-01 지엘팜텍주식회사 프레가발린 함유 경구용 서방성 삼중정제
KR102039345B1 (ko) * 2017-02-01 2019-11-01 지엘팜텍주식회사 프레가발린 함유 고팽윤성 서방성 삼중정제
CN121015618A (zh) * 2020-07-20 2025-11-28 四川海思科制药有限公司 一种稠合三环γ-氨基酸衍生物的缓释药物制剂及其制备方法
CN112245404A (zh) * 2020-11-02 2021-01-22 成都晶富医药科技有限公司 一种普瑞巴林胶囊及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3856816B2 (ja) 1992-05-20 2006-12-13 ノースウェスターン ユニヴァーシティ 抗発作治療用のｇａｂａ及びｌ−グルタミン酸類縁体
ATE245414T1 (de) * 1998-09-14 2003-08-15 Ranbaxy Lab Ltd Oral verabreichtes system zur zeitlich und räumlich gesteuerten arzneistoffabgabe
CA2356829A1 (en) * 2000-09-22 2002-03-22 Warner-Lambert Company Method for treating asthma using pregabalin
US20070184104A1 (en) * 2001-10-25 2007-08-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
CA2491665A1 (fr) * 2004-12-24 2006-06-24 Louis Cartilier Formulation de comprime pour liberation soutenue de principe actif
WO2007048223A2 (en) * 2005-10-25 2007-05-03 Pharmascience Inc. A gastric retention drug delivery system
US20070092565A1 (en) * 2005-10-25 2007-04-26 Pharmascience Inc. Gastric retention drug delivery system
NL2000281C2 (nl) * 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
JP2009522294A (ja) * 2005-12-29 2009-06-11 デポメッド， インコーポレイテッド 胃保持型ガバペンチン投薬形態およびその使用方法
CA2661172A1 (en) * 2006-09-04 2008-05-29 Panacea Biotec Limited Programmable buoyant delivery technology
CA2673336A1 (en) * 2006-12-21 2008-06-26 Xenoport, Inc. Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use
US20110268666A1 (en) * 2008-09-29 2011-11-03 Yissum Research Development Company of the Research University of Jerusalem, Ltd. Novel gastroretentive delivery system
EP2448406B1 (en) * 2009-02-26 2016-04-20 Relmada Therapeutics, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
JP6170918B2 (ja) * 2011-07-26 2017-07-26 ユーハン・コーポレイションＹＵＨＡＮ Ｃｏｒｐｏｒａｔｉｏｎ 二相の放出制御システムによるプレガバリンを含む徐放錠

Similar Documents

Publication Publication Date Title
JP2013535477A5 (https=)
NZ605232A (en) Formulations of rifaximin and uses thereof
CN109072050A (zh) 一种高效环保型抑尘剂及其制备方法、应用
JP2018040002A5 (https=)
HRP20180965T1 (hr) Formulacija lijeka s produženim otpuštanjem
MX352476B (es) Carboximetilcelulosa nueva viscosidad alta y metodo de preparacion.
JP2016525572A5 (https=)
JP2014508095A5 (https=)
WO2017155286A3 (ko) 2,5-퓨란디카르복시산 제조용 촉매 및 이 촉매를 이용한 2,5-퓨란디카르복시산의 제조방법
JP2015516240A5 (https=)
JP2013010803A5 (https=)
MX344742B (es) Composicion de formacion de pelicula para capsulas suaves.
JP2017520577A5 (https=)
CN109415361A (zh) 丙烯酸类衍生物及其制备方法和其在医药上的用途
MX336777B (es) Peliculas y composiciones que comprenden las mismas.
NZ603531A (en) Alcohol-resistant formulations
CN109906077A (zh) 依达拉奉与(+)-2-莰醇的舌下用药物组合物
WO2014118808A3 (en) Ticagrelor solid dispersion
JP2012031240A5 (https=)
JP2011513393A5 (https=)
JP2013535251A5 (https=)
IN2014DE00037A (https=)
JP2014122166A5 (https=)
JP2010521437A5 (https=)
WO2007100822A3 (en) Fluvastatin sodium pharmaceutical compositions